Concepedia

Author

Shenghua Wen

AstraZeneca (United States)ORCID

Also Known As

S. Wen, Shenghua Wen

83

Publications

1.1K

Citations

14

H-Index

38

Concepts

All Affiliations

AstraZeneca (United States)AstraZeneca (United Kingdom)AstraZeneca (France)Millennium Engineering and Integration (United States)AstraZeneca (Singapore)
SW

About

Shenghua Wen is an author at AstraZeneca (United States) specializing in medicine, cell biology, and tumor microenvironment.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

377

2

Cell Biology

3

3

205

3

Immunology

2

2

172

4

Engineering

1

1

15

5

Natural Sciences

1

1

19

Shenghua Wen

×

14

Publications

1K

Citations

14

H-Index

YearCitations

PTEN controls tumor-induced angiogenesis

Shenghua Wen, Javor P. Stolarov, Michael P. Myers,

Proceedings of the National Academy of Sciences

2001

244

A Prostate-Specific Membrane Antigen-Targeted Monoclonal Antibody–Chemotherapeutic Conjugate Designed for the Treatment of Prostate Cancer

Michael D. Henry, Shenghua Wen, Matthew D. Silva,

Cancer Research

2004

155

A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models

Jeffrey L. Brown, Zhe Cao, Maria Pinzon-Ortiz,

Molecular Cancer Therapeutics

2010

150

AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies

Garrett W. Rhyasen, Maureen M. Hattersley, Yi Yao,

Molecular Cancer Therapeutics

2016

147

Design and optimisation of dendrimer-conjugated Bcl-2/xL inhibitor, AZD0466, with improved therapeutic index for cancer therapy

Claire Patterson, Srividya B. Balachander, Iain Grant,

Communications Biology

2021

89

AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-xL, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting Thrombocytopenia

Srividya B. Balachander, Steven W. Criscione, Kate F. Byth,

Clinical Cancer Research

2020

64

Ganglioside GM2/GD2 Synthetase mRNA Is a Marker for Detection of Infrequent Neuroblastoma Cells in Bone Marrow

Dave S.�B. Hoon, Christine Kuo, Shenghua Wen,

American Journal Of Pathology

2001

39

Optimizing Therapeutic Effect of Aurora B Inhibition in Acute Myeloid Leukemia with AZD2811 Nanoparticles

Nicolas Floc’h, Susan Ashton, Paula Taylor,

Molecular Cancer Therapeutics

2017

35

Spiculated periosteal response induced by intraosseous injection of 22Rv1 prostate cancer cells resembles subset of bone metastases in prostate cancer patients

Michael D. Henry, Matthew D. Silva, Shenghua Wen,

The Prostate

2005

30

Development of a new fully human anti-CD20 monoclonal antibody for the treatment of B-cell malignancies

Gadi Gazit Bornstein, Christophe Quéva, Mohammad Tabrizi,

Investigational New Drugs

2009

22

Page 1